Investment Options

Investment Options in the context of an employer-sponsored 401(k) refers to the array of financial vehicles available for employees to allocate their retirement savings. Within a 401(k) plan, employees have the opportunity to invest their contributions into various assets, allowing them to build a diversified portfolio tailored to their risk tolerance and long-term financial goals.

Examples of investment options commonly found in 401(k) plans include:

  • Mutual Funds: These are professionally managed funds that pool money from multiple investors to invest in a diversified range of stocks, bonds, or other securities. Mutual funds offer varying levels of risk and potential returns, making them popular choices for 401(k) participants seeking broad exposure to the market.
  • Target-Date Funds: These funds automatically adjust their asset allocation based on the target retirement date. As the employee approaches retirement, the fund gradually shifts from higher-risk to more conservative investments, reducing exposure to volatility over time.
  • Index Funds: Index funds aim to replicate the performance of a specific market index, such as the S&P 500. They offer a passive investment approach, often with lower fees than actively managed funds, and are suitable for those seeking a "set-it-and-forget-it" investment strategy.

Understanding the available investment options is crucial for employees to make informed decisions about how to grow their retirement savings effectively. Employers typically provide investment education resources to assist participants in navigating these choices and creating a well-balanced 401(k) portfolio

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.